Project Details
Description
A Phase 2 Randomized, Double Blinded, Multi-Center Trial of Amplimexon plus Gemcitabine vs Gemcitabine plus Placebo in Patients with Metastic Chemotherapy Naive Pancreatic Adenocarcinoma (Stage IV)
| Status | Finished |
|---|---|
| Effective start/end date | 1/6/09 → 10/30/10 |
Funding
- AMPLIMED CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.